-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Black Diamond Therapeutic, Maintains $11 Price Target

Benzinga·10/29/2026 10:45:36
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11 price target.